Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ENTX
Stock Latest News
The Fly
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
1d ago
ENTX
Premium
The Fly
Entera Bio announces new data on long-acting PTH tablet
2d ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q3 2025 Financial Results
1M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q3 2025 Results and FDA Agreement
1M ago
8K
ENTX
Premium
The Fly
Entera Bio presents clinical data from EB613 Phase 2 trial
2M ago
ENTX
Premium
Ratings
Entera Bio’s Promising Oral Therapies Drive Buy Rating: Analyst Highlights Developments in GLP-2 and EB613 Programs
3M ago
ENTX
Premium
The Fly
Entera Bio announces presentation of PK data for GLP-2 tablet treatment
3M ago
ENTX
Premium
The Fly
Entera Bio presents data on EB613 in post-menopausal women with osteoporosis
4M ago
ENTX
Premium
The Fly
Entera Bio to present data across three oral peptide programs
4M ago
ENTX
Premium
Ratings
Entera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
5M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
5M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results
5M ago
8K
ENTX
Premium
Company Announcements
Entera Bio Advances EB613 with FDA Approval
5M ago
8K
ENTX
Premium
The Fly
Entera Bio receives FDA agreement on BMD as primary endpoint for EB613 study
5M ago
ENTX
Premium
Company Announcements
Entera Bio Elects New Board Member at Annual Meeting
5M ago
8K
ENTX
Premium
The Fly
Entera Bio announces data for EB613 to be presented at ASBMR 2025
6M ago
ENTX
Premium
The Fly
Entera Bio, Opko Health announce new in vivo data for OPK-88006
6M ago
OPK
ENTX
Premium
The Fly
Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025
6M ago
OPK
ENTX
Premium
The Fly
Entera Bio files $100M mixed securities shelf
7M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q1 2025 Financial Results and Strategic Developments
7M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q1 2025 Results and Strategic Updates
8M ago
8K
ENTX
Premium
The Fly
Entera Bio announces highlights from presentation at WCO-IFO-ESCEO on EB613
8M ago
ENTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
